These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 34383993)

  • 21. Structure-Based Discovery of Small-Molecule Inhibitors of the Autocatalytic Proliferation of α-Synuclein Aggregates.
    Chia S; Faidon Brotzakis Z; Horne RI; Possenti A; Mannini B; Cataldi R; Nowinska M; Staats R; Linse S; Knowles TPJ; Habchi J; Vendruscolo M
    Mol Pharm; 2023 Jan; 20(1):183-193. PubMed ID: 36374974
    [TBL] [Abstract][Full Text] [Related]  

  • 22. SARS-CoV-2 N-protein induces the formation of composite α-synuclein/N-protein fibrils that transform into a strain of α-synuclein fibrils.
    Semerdzhiev SA; Segers-Nolten I; van der Schoot P; Blum C; Claessens MMAE
    Nanoscale; 2023 Nov; 15(45):18337-18346. PubMed ID: 37921451
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Amyloid fibril formation of alpha-synuclein is accelerated by preformed amyloid seeds of other proteins: implications for the mechanism of transmissible conformational diseases.
    Yagi H; Kusaka E; Hongo K; Mizobata T; Kawata Y
    J Biol Chem; 2005 Nov; 280(46):38609-16. PubMed ID: 16162499
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Fundamental mechanisms of amyloid fibril formation by alpha-synuclein in Parkinson's disease: quantitative modelling].
    Galvagnion C; Buell AK
    Med Sci (Paris); 2015; 31(6-7):597-600. PubMed ID: 26152159
    [No Abstract]   [Full Text] [Related]  

  • 25. Human Hsp70 Disaggregase Reverses Parkinson's-Linked α-Synuclein Amyloid Fibrils.
    Gao X; Carroni M; Nussbaum-Krammer C; Mogk A; Nillegoda NB; Szlachcic A; Guilbride DL; Saibil HR; Mayer MP; Bukau B
    Mol Cell; 2015 Sep; 59(5):781-93. PubMed ID: 26300264
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Copper and iron ions accelerate the prion-like propagation of α-synuclein: A vicious cycle in Parkinson's disease.
    Li Y; Yang C; Wang S; Yang D; Zhang Y; Xu L; Ma L; Zheng J; Petersen RB; Zheng L; Chen H; Huang K
    Int J Biol Macromol; 2020 Nov; 163():562-573. PubMed ID: 32629061
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stabilization of α-Synuclein Fibril Clusters Prevents Fragmentation and Reduces Seeding Activity and Toxicity.
    Lam HT; Graber MC; Gentry KA; Bieschke J
    Biochemistry; 2016 Feb; 55(4):675-85. PubMed ID: 26799377
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In Vitro Analysis of α-Synuclein Amyloid Formation and Cross-Reactivity.
    Horvath I; Rocha S; Wittung-Stafshede P
    Methods Mol Biol; 2018; 1779():73-83. PubMed ID: 29886528
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Wild-Type
    Guzzo A; Delarue P; Rojas A; Nicolaï A; Maisuradze GG; Senet P
    Front Mol Biosci; 2022; 9():910104. PubMed ID: 35836937
    [No Abstract]   [Full Text] [Related]  

  • 30. Cytotoxic Oligomers and Fibrils Trapped in a Gel-like State of α-Synuclein Assemblies.
    Kumar R; Das S; Mohite GM; Rout SK; Halder S; Jha NN; Ray S; Mehra S; Agarwal V; Maji SK
    Angew Chem Int Ed Engl; 2018 May; 57(19):5262-5266. PubMed ID: 29524323
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rationally Designed Protein-Based Inhibitor of α-Synuclein Fibrillization in Cells.
    Priss A; Afitska K; Galkin M; Yushchenko DA; Shvadchak VV
    J Med Chem; 2021 May; 64(10):6827-6837. PubMed ID: 33970620
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synergistic Amyloid Switch Triggered by Early Heterotypic Oligomerization of Intrinsically Disordered α-Synuclein and Tau.
    Bhasne K; Sebastian S; Jain N; Mukhopadhyay S
    J Mol Biol; 2018 Aug; 430(16):2508-2520. PubMed ID: 29704492
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Initiation and propagation of α-synuclein aggregation in the nervous system.
    Hijaz BA; Volpicelli-Daley LA
    Mol Neurodegener; 2020 Mar; 15(1):19. PubMed ID: 32143659
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Properties of α-Synuclein Secondary Nuclei Are Dominated by the Solution Conditions Rather than the Seed Fibril Strain.
    Peduzzo A; Linse S; Buell AK
    ACS Chem Neurosci; 2020 Mar; 11(6):909-918. PubMed ID: 32069013
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased Dynamics of α-Synuclein Fibrils by β-Synuclein Leads to Reduced Seeding and Cytotoxicity.
    Yang X; Williams JK; Yan R; Mouradian MM; Baum J
    Sci Rep; 2019 Nov; 9(1):17579. PubMed ID: 31772376
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pressure effects on α-synuclein amyloid fibrils: An experimental investigation on their dissociation and reversible nature.
    Piccirilli F; Plotegher N; Spinozzi F; Bubacco L; Mariani P; Beltramini M; Tessari I; Militello V; Perucchi A; Amenitsch H; Baldassarri E; Steinhart M; Lupi S; Ortore MG
    Arch Biochem Biophys; 2017 Aug; 627():46-55. PubMed ID: 28624352
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Physicochemical characterization of the G51D mutation of α-synuclein that is responsible for its severe cytotoxicity.
    Murata T; Tochio N; Utsunomiya-Tate N
    Neurosci Lett; 2021 Aug; 760():136077. PubMed ID: 34161822
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sensitized Emission Imaging Allows Nanoscale Surface Polarity Mapping of α-Synuclein Amyloid Fibrils.
    Mahato J; Mukherjee R; Bose A; Mehra S; Gadhe L; Maji SK; Chowdhury A
    ACS Chem Neurosci; 2024 Jan; 15(1):108-118. PubMed ID: 38099928
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The H50Q mutation induces a 10-fold decrease in the solubility of α-synuclein.
    Porcari R; Proukakis C; Waudby CA; Bolognesi B; Mangione PP; Paton JF; Mullin S; Cabrita LD; Penco A; Relini A; Verona G; Vendruscolo M; Stoppini M; Tartaglia GG; Camilloni C; Christodoulou J; Schapira AH; Bellotti V
    J Biol Chem; 2015 Jan; 290(4):2395-404. PubMed ID: 25505181
    [TBL] [Abstract][Full Text] [Related]  

  • 40. C-terminal truncation exacerbates the aggregation and cytotoxicity of α-Synuclein: A vicious cycle in Parkinson's disease.
    Ma L; Yang C; Zhang X; Li Y; Wang S; Zheng L; Huang K
    Biochim Biophys Acta Mol Basis Dis; 2018 Dec; 1864(12):3714-3725. PubMed ID: 30290273
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.